The natural history of frozen shoulder varies significantly. Without intervention, the condition typically progresses through three stages — freezing (2–9 months), frozen (4–12 months) and thawing (5–24 months). Total duration can range from 12 months to over 3 years. Some people recover full range of motion; others retain mild restrictions. The Cochrane review found that LLLT combined with exercise may improve pain and function outcomes compared to exercise alone, which may support a more comfortable recovery process.

Yes, and in fact gentle use is encouraged. The evidence supports cold laser therapy alongside exercise — not instead of it. Avoiding use of the shoulder (while tempting when it is painful) can lead to further stiffening. The key is working within your comfortable range and gradually progressing as your mobility improves.

Night pain is one of the hallmark features of frozen shoulder. When lying down, the inflamed joint capsule is compressed, and the absence of daytime movement allows the capsule to stiffen further. Many people find that sleeping on the unaffected side with a pillow supporting the affected arm provides some relief.

Your first visit is $99, which includes a thorough assessment and treatment where clinically appropriate. Ongoing care options are discussed at your initial consultation. Most private health funds cover part of the cost under chiropractic extras. No lock-in plans. If you prepay for sessions you do not end up using, we refund them in full. The decision is always yours.

Frozen shoulder does have a natural history of eventual resolution, and your GP is correct about that. However, “eventual” can mean 1–3 years, and many people retain some residual restriction. The question is whether you want to wait — potentially in significant pain — or explore approaches that the evidence suggests may help manage symptoms and support recovery along the way. A Cochrane review found moderate evidence that LLLT combined with exercise improves outcomes compared to exercise alone. Individual responses vary.

Yes. Cortisone injections and photobiomodulation work through different mechanisms. Cortisone suppresses local inflammation (which can provide temporary relief), while PBM delivers light energy that may influence cellular processes and tissue remodelling. The two approaches are not mutually exclusive. Many people explore photobiomodulation when injection relief has been temporary or when they prefer to avoid repeat injections.

Frozen shoulder is distinct because it involves the joint capsule itself — the “sleeve” that surrounds the shoulder joint. Other conditions like rotator cuff injuries or impingement involve the muscles and tendons around the joint. In frozen shoulder, the capsule becomes inflamed, thickened and contracted, which progressively restricts movement in all directions. This is why stretching alone often feels ineffective — the capsule is physically preventing the movement.

Yes. Diabetes is one of the strongest risk factors for adhesive capsulitis. People with diabetes are 2–4 times more likely to develop frozen shoulder, and the condition tends to be more severe and longer-lasting. The exact mechanism is not fully understood, but it is thought to relate to the effects of elevated blood glucose on connective tissue. If you have diabetes and are developing shoulder stiffness, early assessment is recommended.

We use the Multi-Radiance MR5 ACTIV PRO, an ARTG-listed (370913) super-pulsed laser device. It delivers multiple wavelengths including 905 nm super-pulsed laser, 875 nm infrared and 640 nm red light. The Cochrane review and other trials used various LLLT devices with wavelengths typically in the 780–904 nm range, which falls within the spectrum delivered by our device.

Most people recover a significant proportion of their range of motion, though some retain mild restrictions that may not be noticeable in daily activities. The Cochrane review found that LLLT combined with exercise improved function outcomes that were maintained at 4 months. Recovery depends on multiple factors including the severity of capsular involvement, how long the condition has been present, and individual biology. Individual responses vary.

Approximately 6–17% of people with frozen shoulder will develop it in the other shoulder, though typically not at the same time. Having had frozen shoulder on one side is a risk factor for developing it on the other. The condition rarely recurs in the same shoulder.